MQS Management LLC Purchases New Stake in Aveanna Healthcare Holdings Inc. $AVAH

MQS Management LLC purchased a new stake in Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 11,197 shares of the company’s stock, valued at approximately $59,000.

Several other institutional investors have also recently added to or reduced their stakes in AVAH. Banque Transatlantique SA acquired a new stake in Aveanna Healthcare in the first quarter valued at $25,000. Diversified Trust Co acquired a new stake in Aveanna Healthcare in the second quarter valued at $57,000. Jump Financial LLC acquired a new stake in Aveanna Healthcare in the first quarter valued at $59,000. AQR Capital Management LLC raised its holdings in Aveanna Healthcare by 21.2% in the first quarter. AQR Capital Management LLC now owns 26,280 shares of the company’s stock valued at $142,000 after acquiring an additional 4,602 shares in the last quarter. Finally, Cornerstone Investment Partners LLC acquired a new stake in Aveanna Healthcare in the first quarter valued at $167,000. 87.96% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several analysts have weighed in on the stock. Wall Street Zen upgraded shares of Aveanna Healthcare from a “buy” rating to a “strong-buy” rating in a research note on Saturday, August 9th. Raymond James Financial upgraded shares of Aveanna Healthcare from a “market perform” rating to an “outperform” rating and set a $9.00 target price for the company in a research note on Monday, August 11th. Weiss Ratings reiterated a “hold (c)” rating on shares of Aveanna Healthcare in a research note on Wednesday, October 8th. Jefferies Financial Group boosted their target price on shares of Aveanna Healthcare from $11.00 to $12.50 and gave the company a “buy” rating in a research note on Tuesday. Finally, Barclays upgraded shares of Aveanna Healthcare from an “equal weight” rating to an “overweight” rating and boosted their target price for the company from $5.50 to $9.50 in a research note on Tuesday, August 19th. Three equities research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company’s stock. Based on data from MarketBeat, Aveanna Healthcare has an average rating of “Hold” and an average target price of $9.29.

Aveanna Healthcare Stock Performance

Aveanna Healthcare stock opened at $9.81 on Wednesday. The company has a 50-day simple moving average of $8.60 and a 200-day simple moving average of $6.24. The firm has a market capitalization of $2.05 billion, a P/E ratio of 122.63 and a beta of 2.05. Aveanna Healthcare Holdings Inc. has a one year low of $3.67 and a one year high of $10.32.

Aveanna Healthcare (NASDAQ:AVAH) last released its quarterly earnings results on Monday, May 22nd. The company reported $0.04 EPS for the quarter. The business had revenue of $450.53 million during the quarter. Aveanna Healthcare had a net margin of 0.85% and a negative return on equity of 54.56%. As a group, sell-side analysts forecast that Aveanna Healthcare Holdings Inc. will post -0.06 earnings per share for the current year.

Insider Transactions at Aveanna Healthcare

In other news, major shareholder Robert M. Williams, Jr. sold 10,000,000 shares of the company’s stock in a transaction dated Tuesday, October 21st. The shares were sold at an average price of $9.00, for a total transaction of $90,000,000.00. Following the completion of the transaction, the insider owned 386,284 shares in the company, valued at approximately $3,476,556. This represents a 96.28% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, major shareholder J.H. Whitney Equity Partners V sold 8,346,059 shares of the stock in a transaction dated Tuesday, October 21st. The shares were sold at an average price of $9.00, for a total transaction of $75,114,531.00. Following the completion of the transaction, the insider owned 20,544,696 shares of the company’s stock, valued at $184,902,264. This represents a 28.89% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last quarter, insiders sold 32,597,968 shares of company stock worth $293,381,712. Insiders own 7.00% of the company’s stock.

Aveanna Healthcare Profile

Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.